Last week Justice Edelman delivered judgment in the Federal Court, finding that Reckitt Benckiser (Australia)’s packaging and website descriptions of the Nurofen ‘Specific Pain Range’ constituted misleading or deceptive conduct under section 18 of the Australian Consumer Law (‘ACL’).
The Federal Court of Australia has found that Reckitt Benckiser engaged in misleading and deceptive conduct in the packaging and online information about a range of Nurofen products